Isabelle Dubus
Rouen, 76000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Preclinical efficacy of adipose-derived cell therapies for the treatment of myositis.
Journal: Stem cells translational medicine
Published: January 10, 2025
Stromal vascular fraction in the treatment of myositis.
Journal: Cell death discovery
Published: March 13, 2023
Modulation of glucocorticoid sensitivity in acute lymphoblastic leukemia: Pyr3, a new therapeutic tool?
Journal: Medecine sciences : M/S
Published: February 28, 2017
Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation.
Journal: Oncotarget
Published: November 16, 2016
Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production.
Journal: European journal of pharmacology
Published: April 04, 2016
Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
Journal: Pharmacological research
Published: June 03, 2013
Importance of local hypoxia on endothelial phenotype for an in vitro approach to bone marrow angiogenesis.
Journal: Leukemia research
Published: January 30, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026